Bone Morphogenetic Protein 2 and Transforming Growth Factor β1 Inhibit the Expression of the Proinflammatory Cytokine IL-34 in Rheumatoid Arthritis Synovial Fibroblasts
- 1 January 2017
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 187 (1) , 156-162
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patientsAnnals of the Rheumatic Diseases, 2012
- Interleukin‐34 is expressed by giant cell tumours of bone and plays a key role in RANKL‐induced osteoclastogenesisThe Journal of Pathology, 2010
- Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritisImmunological Reviews, 2009
- TGF-β and fibrosis in different organs — molecular pathway imprintsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Rheumatoid arthritisThe Lancet, 2009
- Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular ProteomeScience, 2008
- Constitutive upregulation of the transforming growth factor-β pathway in rheumatoid arthritis synovial fibroblastsArthritis Research & Therapy, 2007
- Transforming growth factor beta 1(TGF-β1) down-regulates TNFα-induced RANTES production in rheumatoid synovial fibroblasts through NF-κB-mediated transcriptional repressionImmunology Letters, 2006
- Susceptibility to collagen-induced arthritis is modulated by TGFβ responsiveness of T cellsArthritis Research & Therapy, 2004
- Dynamic expression of transforming growth factor-betas (TGF-β) and their type I and type II receptors in the synovial tissue of arthritic ratsClinical and Experimental Immunology, 1997